Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Metastatic to Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07206498
What this trial is testing

Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Wayshine Biopharm, Inc. 48
Testing effectiveness (Phase 2)Ended earlyNCT01518621
What this trial is testing

Whole Brain Radiation With or Without Erlotinib for Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Cancer
Oslo University Hospital 25
Not applicableUnknownNCT04689321
What this trial is testing

Revision of the EORTC QLQ-BN20 Questionnaire

Who this might be right for
GliomaBrain Metastases, Adult
Leiden University Medical Center 135
Post-approval studies (Phase 4)Study completedNCT05054998
What this trial is testing

Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm
M.D. Anderson Cancer Center 12
Not applicableUnknownNCT01890278
What this trial is testing

Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases

Who this might be right for
Metastatic Brain Cancer
Good Samaritan Hospital Medical Center, New York 60
Not applicableUnknownNCT04787185
What this trial is testing

Stereotactic Radiotherapy in Association With Immunotherapy for the Treatment of NSCLC Brain Metastases

Who this might be right for
Brain Metastases From NSCLC
Azienda Ospedaliero-Universitaria Careggi 50
Testing effectiveness (Phase 2)Study completedNCT00541138
What this trial is testing

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 50
Not applicableUnknownNCT03226483
What this trial is testing

Intraoperative Radiotherapy After the Resection of Brain Metastases

Who this might be right for
Brain Metastases
Universitätsmedizin Mannheim 50
Testing effectiveness (Phase 2)Study completedNCT03520842
What this trial is testing

Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer

Who this might be right for
KRAS Gene MutationMetastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung Carcinoma+1 more
Stanford University 22
Large-scale testing (Phase 3)Study completedNCT05807893
What this trial is testing

Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer Stage IIBevacizumabImmunotherapy+1 more
Sun Yat-sen University 40
Not applicableLooking for participantsNCT06231186
What this trial is testing

A Feasibility Study of iHD-SRT for BM

Who this might be right for
Brain Metastases, AdultStereotactic Radiotherapy
Ruijin Hospital 35
Early research (Phase 1)Ended earlyNCT00089245
What this trial is testing

Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaSarcoma
Y-mAbs Therapeutics 177
Not applicableStudy completedNCT04890028
What this trial is testing

Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases

Who this might be right for
Brain MetastasesMRI
Institut Cancerologie de l'Ouest 32
Not applicableActive Not RecruitingNCT03775330
What this trial is testing

Radiosurgery With or Without Whole Brain Radiation for Multiple Metastases

Who this might be right for
Brain Metastases
Sunnybrook Health Sciences Centre 126
Testing effectiveness (Phase 2)UnknownNCT01688713
What this trial is testing

Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasesNon-small Cell Lung Cancer
Zhejiang Cancer Hospital 20
Early research (Phase 1)Looking for participantsNCT02390518
What this trial is testing

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

Who this might be right for
Brain Metastases
University of Utah 86
Early research (Phase 1)Looking for participantsNCT07361562
What this trial is testing

A Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor, AdultERBB2 Altered Breast CancerERBB2 Gene Amplification+3 more
Cogent Biosciences, Inc. 100
Testing effectiveness (Phase 2)Looking for participantsNCT07638852
What this trial is testing

Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.

Who this might be right for
TNBC, Triple Negative Breast CancerBrain Metastasases
Fudan University 58
Testing effectiveness (Phase 2)Study completedNCT00003878
What this trial is testing

Carmustine Implants in Treating Patients With Brain Metastases

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Active Not RecruitingNCT01644591
What this trial is testing

Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more
M.D. Anderson Cancer Center 49
Next Page